Improving care in high-risk post-myocardial infarction patients: from pilot to national roll-out

• At: Glasgow (Scotland) (2018)
• Type: Poster
• Poster code: POS-HPS-056
• By: FORSYTH, Paul (NHS Greater Glasgow & Clyde, Pharmacy & Prescribing Support Unit (PPSU))
• Co-author(s): Paul Forsyth
  Lynsey Moir: Pharmacy & Prescribing Support Unit (PPSU), NHS Greater Glasgow & Clyde, Glasgow, United Kingdom
  Iain Speirits: Pharmacy & Prescribing Support Unit (PPSU), NHS Greater Glasgow & Clyde, Glasgow, United Kingdom
  Fiona Reid: Pharmacy, NHS Education for Scotland, Glasgow, United Kingdom
  Anne Watson: Pharmacy, NHS Education for Scotland, Glasgow, United Kingdom
  Steve McGlynn: Pharmacy & Prescribing Support Unit (PPSU), NHS Greater Glasgow & Clyde, Glasgow, United Kingdom
  Clare Murphy: Cardiology Department, Royal Alexandra Hospital, NHS Greater Glasgow & Clyde, Paisley, United Kingdom
  
• Abstract:

  Background

  Left ventricular systolic dysfunction (LVSD) is one of the strongest predictors of outcomes Post-Myocardial Infarction (Post-MI).¹ The optimisation of angiotensin converting enzyme inhibitors (ACEIs) and beta-blockers (βBs) is crucial in improving outcomes.²

   

  Methods

  Quality improvement project in patients with incident MI and echo
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login